LY2875358, ERLOTINIB
I4C-MC-JTBB
Phase 2 small_molecule active
Quick answer
LY2875358, ERLOTINIB for Non-Small Cell Lung Cancer is a Phase 2 program (small_molecule) at Eli Lilly Co. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eli Lilly Co.
- Indication
- Non-Small Cell Lung Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active